Recursion Pharmaceuticals Stock Forward View - Accumulation Distribution
| RXRX Stock | USD 3.71 0.14 3.64% |
Recursion Stock outlook is based on your current time horizon.
At this time the rsi of Recursion Pharmaceuticals' share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.34) | EPS Estimate Current Year (1.60) | EPS Estimate Next Year (1.17) | Wall Street Target Price 7 | EPS Estimate Current Quarter (0.38) |
Using Recursion Pharmaceuticals hype-based prediction, you can estimate the value of Recursion Pharmaceuticals from the perspective of Recursion Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Recursion Pharmaceuticals using Recursion Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Recursion using crowd psychology based on the activity and movement of Recursion Pharmaceuticals' stock price.
Recursion Pharmaceuticals Short Interest
An investor who is long Recursion Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Recursion Pharmaceuticals and may potentially protect profits, hedge Recursion Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 4.9604 | Short Percent 0.3369 | Short Ratio 8.17 | Shares Short Prior Month 163.4 M | 50 Day MA 4.4474 |
Recursion Relative Strength Index
Recursion Pharmaceuticals Hype to Price Pattern
Investor biases related to Recursion Pharmaceuticals' public news can be used to forecast risks associated with an investment in Recursion. The trend in average sentiment can be used to explain how an investor holding Recursion can time the market purely based on public headlines and social activities around Recursion Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Recursion Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Recursion Pharmaceuticals.
Recursion Pharmaceuticals Implied Volatility | 1.25 |
Recursion Pharmaceuticals' implied volatility exposes the market's sentiment of Recursion Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Recursion Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Recursion Pharmaceuticals stock will not fluctuate a lot when Recursion Pharmaceuticals' options are near their expiration.
Recursion Pharmaceuticals after-hype prediction price | USD 3.71 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Recursion | Build AI portfolio with Recursion Stock |
Prediction based on Rule 16 of the current Recursion contract
Based on the Rule 16, the options market is currently suggesting that Recursion Pharmaceuticals will have an average daily up or down price movement of about 0.0781% per day over the life of the 2026-03-27 option contract. With Recursion Pharmaceuticals trading at USD 3.71, that is roughly USD 0.002898 . If you think that the market is fully incorporating Recursion Pharmaceuticals' daily price movement you should consider acquiring Recursion Pharmaceuticals options at the current volatility level of 1.25%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-27 Recursion Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Recursion Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Recursion Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Recursion Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Recursion Pharmaceuticals' open interest, investors have to compare it to Recursion Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Recursion Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Recursion. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Recursion Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Recursion price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Recursion using various technical indicators. When you analyze Recursion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 677693.0 | 1.5 M |
| Check Recursion Pharmaceuticals Volatility | Backtest Recursion Pharmaceuticals | Information Ratio |
Recursion Pharmaceuticals Trading Date Momentum
| On February 11 2026 Recursion Pharmaceuticals was traded for 3.71 at the closing time. The top price for the day was 3.88 and the lowest listed price was 3.64 . The trading volume for the day was 24 M. The trading history from February 11, 2026 did not cause price change. The trading delta at closing time against the current closing price is 4.31% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Recursion Pharmaceuticals to competition |
Other Forecasting Options for Recursion Pharmaceuticals
For every potential investor in Recursion, whether a beginner or expert, Recursion Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Recursion Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Recursion. Basic forecasting techniques help filter out the noise by identifying Recursion Pharmaceuticals' price trends.Recursion Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Recursion Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Recursion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Recursion Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Recursion Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Recursion Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Recursion Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Recursion Pharmaceuticals stock market strength indicators, traders can identify Recursion Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 1.5 M | |||
| Daily Balance Of Power | (0.58) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 3.76 | |||
| Day Typical Price | 3.74 | |||
| Price Action Indicator | (0.12) | |||
| Period Momentum Indicator | (0.14) |
Recursion Pharmaceuticals Risk Indicators
The analysis of Recursion Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Recursion Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting recursion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.4 | |||
| Standard Deviation | 4.35 | |||
| Variance | 18.91 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Recursion Pharmaceuticals
The number of cover stories for Recursion Pharmaceuticals depends on current market conditions and Recursion Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Recursion Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Recursion Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Recursion Pharmaceuticals Short Properties
Recursion Pharmaceuticals' future price predictability will typically decrease when Recursion Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Recursion Pharmaceuticals often depends not only on the future outlook of the potential Recursion Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Recursion Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 274.2 M | |
| Cash And Short Term Investments | 594.4 M |
Additional Tools for Recursion Stock Analysis
When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.